BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33669421)

  • 1. A Novel Effective and Safe Vaccine for Prevention of Marek's Disease Caused by Infection with a Very Virulent Plus (vv+) Marek's Disease Virus.
    Liao Y; Reddy SM; Khan OA; Sun A; Lupiani B
    Vaccines (Basel); 2021 Feb; 9(2):. PubMed ID: 33669421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fully Attenuated
    Sun A; Zhao X; Zhu X; Kong Z; Liao Y; Teng M; Yao Y; Luo J; Nair V; Zhuang G; Zhang G
    Microbiol Spectr; 2022 Dec; 10(6):e0287122. PubMed ID: 36350141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lorf9 deletion significantly eliminated lymphoid organ atrophy induced by meq-deleted very virulent Marek's disease virus.
    Sun A; Luo J; Wan B; Du Y; Wang X; Weng H; Cao X; Zhang T; Chai S; Zhao D; Xing G; Zhuang G; Zhang G
    Vet Microbiol; 2019 Aug; 235():164-169. PubMed ID: 31282374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of the Viral Thymidine Kinase in a Meq-Deleted Recombinant Marek's Disease Virus Reduces Lymphoid Atrophy but Is Less Protective.
    Conrad SJ; Oluwayinka EB; Heidari M; Mays JK; Dunn JR
    Microorganisms; 2021 Dec; 10(1):. PubMed ID: 35056456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of a meq-deleted rmd5 Marek's disease vaccine: protection against virulent MDV challenge and induction of lymphoid organ atrophy are simultaneously attenuated by serial passage in vitro.
    Lee LF; Kreager K; Heidari M; Zhang H; Lupiani B; Reddy SM; Fadly A
    Avian Dis; 2013 Jun; 57(2 Suppl):491-7. PubMed ID: 23901766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell culture attenuation eliminates rMd5ΔMeq-induced bursal and thymic atrophy and renders the mutant virus as an effective and safe vaccine against Marek's disease.
    Lee LF; Heidari M; Zhang H; Lupiani B; Reddy SM; Fadly A
    Vaccine; 2012 Jul; 30(34):5151-8. PubMed ID: 22687760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative evaluation of the protective efficacy of rMd5deltaMeq and CVI988/ Rispens against a vv+ strain of Marek's disease virus infection in a series of recombinant congenic strains of White Leghorn chickens.
    Chang S; Ding Z; Dunn JR; Lee LF; Heidari M; Song J; Ernst CW; Zhang H
    Avian Dis; 2011 Sep; 55(3):384-90. PubMed ID: 22017035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Protection Efficacy of a Serotype 1 Marek's Disease Virus-Vectored Bivalent Vaccine Against Infectious Laryngotracheitis and Marek's Disease.
    Gimeno IM; Cortes AL; Faiz NM; Hernandez-Ortiz BA; Guy JS; Hunt HD; Silva RF
    Avian Dis; 2015 Jun; 59(2):255-62. PubMed ID: 26473676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
    Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
    Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Meq-vIL8 in regulating Marek's disease virus pathogenesis.
    Liao Y; Bajwa K; Al-Mahmood M; Gimeno IM; Reddy SM; Lupiani B
    J Gen Virol; 2021 Feb; 102(2):. PubMed ID: 33236979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Codon Deoptimization of UL54 in meq-Deleted Marek's Disease Vaccine Candidate Eliminates Lymphoid Atrophy but Reduces Vaccinal Protection.
    Conrad SJ; Hearn CJ; Silva RF; Dunn JR
    Avian Dis; 2020 Sep; 64(3):243-246. PubMed ID: 33205163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of a UL5 helicase-primase subunit point mutation eliminates bursal-thymic atrophy of Marek's disease virus ∆Meq recombinant virus but reduces vaccinal protection.
    Hildebrandt E; Dunn JR; Cheng HH
    Avian Pathol; 2015; 44(4):254-8. PubMed ID: 25968878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression of Vaccinal Immunity to Marek's Disease by Infection with Chicken Infectious Anemia Virus.
    Zhang Y; Cui N; Han N; Wu J; Cui Z; Su S
    Front Microbiol; 2017; 8():1863. PubMed ID: 29018431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recombinant field strain of Marek's disease (MD) virus with reticuloendotheliosis virus long terminal repeat insert lacking the meq gene as a vaccine against MD.
    Su S; Cui N; Zhou Y; Chen Z; Li Y; Ding J; Wang Y; Duan L; Cui Z
    Vaccine; 2015 Jan; 33(5):596-603. PubMed ID: 25562789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens.
    Lee LF; Kreager KS; Arango J; Paraguassu A; Beckman B; Zhang H; Fadly A; Lupiani B; Reddy SM
    Vaccine; 2010 Feb; 28(5):1294-9. PubMed ID: 19941987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of a recombinant Marek's disease virus in vivo through expression of the Marek's EcoRI-Q (Meq)-encoded oncoprotein: characterization of an rMd5-based mutant expressing the Meq of strain RB-1B.
    Kumar P; Dong H; Lenihan D; Gaddamanugu S; Katneni U; Shaikh S; Tavlarides-Hontz P; Reddy SM; Peters W; Parcells MS
    Avian Dis; 2012 Jun; 56(2):328-40. PubMed ID: 22856190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of the Meq gene significantly decreases immunosuppression in chickens caused by pathogenic Marek's disease virus.
    Li Y; Sun A; Su S; Zhao P; Cui Z; Zhu H
    Virol J; 2011 Jan; 8():2. PubMed ID: 21205328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of a recombinant Marek's disease virus lacking the meq oncogene and evaluation on its immune efficacy against Marek's disease virus.
    Sun P; Cui N; Liu L; Su S; Cheng Z; Chen R; Li Y; Cui Z
    Poult Sci; 2020 Apr; 99(4):1939-1945. PubMed ID: 32241474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotype 1 viruses modified by backpassage or insertional mutagenesis: approaching the threshold of vaccine efficacy in Marek's disease.
    Witter RL; Kreager KS
    Avian Dis; 2004 Dec; 48(4):768-82. PubMed ID: 15666858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses.
    Buscaglia C; Nervi P; Risso M
    Avian Pathol; 2004 Apr; 33(2):190-5. PubMed ID: 15276986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.